Celularity (CELU) Accumulated Expenses (2020 - 2026)
Celularity's Accumulated Expenses was $32.57 million in Q4 2025, up 59.0% from $20.49 million a year earlier and up 10.7% from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Accumulated Expenses (2020 - 2026) Analysis & Trends
From Q4 2020 onward, Celularity has reported Accumulated Expenses for 19 quarters.
- Accumulated Expenses shows a five-year compound annual growth rate of 19.4% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $20.49 million in FY2024 (+170.3%), $7.58 million in FY2023 (-16.4%), $9.07 million in FY2022 (-22.2%) and $11.66 million in FY2021 (-13.3%).
- Quarterly Accumulated Expenses has moved between $7.58 million (Q4 2023) and $33.37 million (Q2 2025) over five years.
- Compared with a year earlier, Accumulated Expenses has increased for seven straight quarters, with growth averaging 98.2% over the last eight quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q2 2025 (growth of 221.4%); the worst was Q2 2023 (a decline of 54.1%).
- Per Business Quant data, CELU's Accumulated Expenses in the three quarters before Q4 2025 was $29.42 million (Q3 2025), $33.37 million (Q2 2025) and $25.25 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 30.90 Mn |
| Dec 31, 2025 | 32.57 Mn |
| Sep 30, 2025 | 29.42 Mn |
| Jun 30, 2025 | 33.37 Mn |
| Mar 31, 2025 | 25.25 Mn |
| Dec 31, 2024 | 20.49 Mn |
| Sep 30, 2024 | 14.47 Mn |
| Jun 30, 2024 | 10.38 Mn |
| Mar 31, 2024 | 8.76 Mn |
| Dec 31, 2023 | 7.58 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | 9.40 Mn |
| Mar 31, 2023 | 9.56 Mn |
| Dec 31, 2022 | 9.07 Mn |
| Sep 30, 2022 | 18.51 Mn |
| Jun 30, 2022 | 20.48 Mn |
| Mar 31, 2022 | 13.44 Mn |
| Dec 31, 2021 | 11.66 Mn |
| Sep 30, 2021 | 17.10 Mn |
| Dec 31, 2020 | 13.45 Mn |
API Access
Celularity Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();